Filter by
News (17)
RSS![Document icon in a blue background.](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_ratio_3_2_medium/public/2023-12/MicrosoftTeams-image%20%2816%29.png?itok=lVHWoA38)
The report from the annual Multi-stakeholder platform meeting in October 2024 is now available.
![Medical professional looking at desktop screen](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_ratio_3_2_medium/public/2024-01/AdobeStock_603009000%20%281%29.jpeg?itok=6Gvt3Ajm)
The Clinical Trials Information System now supports submission, assessment and oversight of all trials in the EU
![](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_ratio_3_2_medium/public/2025-01/AdobeStock_589197902.jpeg?h=0775493e&itok=224uFjAB)
The ACT EU workplan for 2025-2026 outlines the initiative's areas of focus, which reflect feedback from stakeholders.
![Scientist sitting at her workplace in modern laboratory](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_ratio_3_2_medium/public/2025-01/AdobeStock_400378921.jpeg?h=f21ada27&itok=7XuBAxTh)
The revised ICH guideline on good clinical practice (principles and Annex 1) have been published.
![](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_ratio_3_2_medium/public/2024-09/AdobeStock_238385758.jpeg?h=5de4d5d8&itok=By0H8s3B)
The enhanced portal aims to benefit the public by making it easier to search for publicly available information on clinical trials in the EU and EEA.
![](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_ratio_3_2_medium/public/2024-07/AdobeStock_378144124.jpeg?h=51a72048&itok=1H_AJMiG)
ACT EU has published two new webpages with information of interest to the network and clinical trial stakeholders.
![Female medical research scientist working in a modern laboratory and typing information obtained from new experimental drug trial](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_ratio_3_2_medium/public/2023-09/ACT-EU_news_clinical%20trials.png?itok=8GzIlCgY)
Revised rules for Clinical Trials Information System (CTIS) become applicable.
![](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_ratio_3_2_medium/public/2024-06/AdobeStock_655082213.jpeg?h=3d38b876&itok=cVQJbUAU)
Pilots are part of ACT EU collaboration to foster high-quality clinical research in the EU.
![](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_ratio_3_2_medium/public/2024-04/AdobeStock_595278401.jpeg?h=fa5f4214&itok=4QaqC787)
The revised transparency rules for the Clinical Trials Information System (CTIS) will become applicable on 18 June 2024, with the launch of a new version of the CTIS public portal.
![](https://accelerating-clinical-trials.europa.eu/sites/default/files/styles/oe_theme_ratio_3_2_medium/public/2024-03/AdobeStock_198189095.jpeg?h=fa1c963e&itok=WhXmjh5w)
The Accelerating Clinical Trials in the EU (ACT EU) initiative has established a multi-stakeholder platform (MSP) aimed at improving the environment for clinical trials across the European Union (EU).